Literature DB >> 29582492

Long non-coding RNAs in melanoma.

Xin Yu1, Heyi Zheng1, Gary Tse2, Matthew Tv Chan3, William Kk Wu3,4.   

Abstract

Melanoma is the most lethal cutaneous cancer with a highly aggressive and metastatic phenotype. While recent genetic and epigenetic studies have shed new insights into the mechanism of melanoma development, the involvement of regulatory non-coding RNAs remain unclear. Long non-coding RNAs (lncRNAs) are a group of endogenous non-protein-coding RNAs with the capacity to regulate gene expression at multiple levels. Recent evidences have shown that lncRNAs can regulate many cellular processes, such as cell proliferation, differentiation, migration and invasion. In the melanoma, deregulation of a number of lncRNAs, such as HOTAIR, MALAT1, BANCR, ANRIL, SPRY-IT1 and SAMMSON, have been reported. Our review summarizes the functional role of lncRNAs in melanoma and their potential clinical application for diagnosis, prognostication and treatment.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  SLNCR1; UCA1; lncRNA; prognosis

Mesh:

Substances:

Year:  2018        PMID: 29582492      PMCID: PMC6528844          DOI: 10.1111/cpr.12457

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  63 in total

Review 1.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 2.  Melanoma.

Authors:  Arlo J Miller; Martin C Mihm
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

3.  Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma.

Authors:  Xiao-Song Wang; Zheng Zhang; Hong-Cheng Wang; Jian-Liang Cai; Qing-Wen Xu; Meng-Qiang Li; Yi-Cheng Chen; Xiao-Ping Qian; Tian-Jing Lu; Li-Zhang Yu; Yu Zhang; Dian-Qi Xin; Yan-Qun Na; Wei-Feng Chen
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

4.  MALAT1 long non-coding RNA in cancer.

Authors:  Rei Yoshimoto; Akila Mayeda; Minoru Yoshida; Shinichi Nakagawa
Journal:  Biochim Biophys Acta       Date:  2015-10-03

5.  The non-coding RNA llme23 drives the malignant property of human melanoma cells.

Authors:  Chuan-Fang Wu; Guang-Hong Tan; Cheng-Chuan Ma; Ling Li
Journal:  J Genet Genomics       Date:  2013-03-08       Impact factor: 4.275

6.  Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival.

Authors:  Yan Nie; Xiang Liu; Shaohua Qu; Erwei Song; Hua Zou; Chang Gong
Journal:  Cancer Sci       Date:  2013-01-30       Impact factor: 6.716

Review 7.  Long non-coding RNA HOTAIR: A novel oncogene (Review).

Authors:  Xin Yu; Zheng Li
Journal:  Mol Med Rep       Date:  2015-07-31       Impact factor: 2.952

Review 8.  Long non-coding RNAs in melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Matthew Tv Chan; William Kk Wu
Journal:  Cell Prolif       Date:  2018-03-26       Impact factor: 6.831

9.  Melanoma addiction to the long non-coding RNA SAMMSON.

Authors:  Eleonora Leucci; Roberto Vendramin; Marco Spinazzi; Patrick Laurette; Mark Fiers; Jasper Wouters; Enrico Radaelli; Sven Eyckerman; Carina Leonelli; Katrien Vanderheyden; Aljosja Rogiers; Els Hermans; Pieter Baatsen; Stein Aerts; Frederic Amant; Stefan Van Aelst; Joost van den Oord; Bart de Strooper; Irwin Davidson; Denis L J Lafontaine; Kris Gevaert; Jo Vandesompele; Pieter Mestdagh; Jean-Christophe Marine
Journal:  Nature       Date:  2016-03-24       Impact factor: 49.962

10.  The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.

Authors:  Karyn Schmidt; Cailin E Joyce; Frank Buquicchio; Adam Brown; Justin Ritz; Robert J Distel; Charles H Yoon; Carl D Novina
Journal:  Cell Rep       Date:  2016-05-19       Impact factor: 9.423

View more
  30 in total

Review 1.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

2.  A novel 7‑hypoxia‑related long non‑coding RNA signature associated with prognosis and proliferation in melanoma.

Authors:  Yi Luo; Tinghao Li; Hengguang Zhao; Aijun Chen
Journal:  Mol Med Rep       Date:  2022-06-15       Impact factor: 3.423

Review 3.  Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches.

Authors:  Ion G Motofei
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

Review 4.  Long non-coding RNAs in melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Matthew Tv Chan; William Kk Wu
Journal:  Cell Prolif       Date:  2018-03-26       Impact factor: 6.831

5.  LncRNA MIAT promotes the proliferation, migration, and invasion of melanoma cells through recruiting TCF12 and activating NFAT5.

Authors:  Fei Lu; Ying Song; Shuo Cui; Huafei Zhao; Yuhua Chen; Hao Du
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493.

Authors:  Fan Yang; Pengzhen Lei; Weihui Zeng; Jianwu Gao; Na Wu
Journal:  Cancer Manag Res       Date:  2020-05-05       Impact factor: 3.989

7.  HIX003209 promotes vascular smooth muscle cell migration and proliferation through modulating miR-6089.

Authors:  Xiaofeng Shi; Shuang Pan; Li Li; Yongqi Li; Wei Ma; Han Wang; Caiming Xu; Lei Li; Dong Wang
Journal:  Aging (Albany NY)       Date:  2020-05-27       Impact factor: 5.682

8.  Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4.

Authors:  Yakun Yin; Bin Zhao; Dongqin Li; Guangwen Yin
Journal:  Cell Biosci       Date:  2018-07-13       Impact factor: 7.133

9.  A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.

Authors:  Yi Ding; Tian Li; Min Li; Tuersong Tayier; MeiLin Zhang; Long Chen; ShuMei Feng
Journal:  Biomed Res Int       Date:  2021-06-18       Impact factor: 3.411

10.  Whole‑genome identification and systematic analysis of lncRNA‑mRNA co‑expression profiles in patients with cutaneous basal cell carcinoma.

Authors:  Jiaan Zhang; Xuyue Zhou; Chenpu Zhu; Yu Hu; Rong Li; Shuang Jin; Dan Huang; Mei Ju; Kun Chen; Chao Luan
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.